Opinion: Is private equity a villain in healthcare?

By Forbes
| July 10, 2024

If private equity firms fail to improve their targets, they will lose both money due to the low proceeds from selling them and reputation capital, critical for future deals.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...